Structures by: Iqbal R.
Total: 15
N-Benzoyl-N'-methyl-N'-(p-tolylsulfonyl)hydrazine
C15H16N2O3S
Acta Crystallographica Section E (2006) 62, 7 o3049-o3051
a=9.839(6)Å b=10.937(4)Å c=13.836(8)Å
α=90.00° β=90.00° γ=90.00°
1-[(4-Methylphenyl)sulfonyl]pyrrolidin-2-one
C11H13NO3S
Acta Crystallographica Section E (2006) 62, 7 o2955-o2957
a=8.144(5)Å b=13.717(10)Å c=10.644(8)Å
α=90.00° β=108.27(3)° γ=90.00°
N-{[1-(5-benzylthio)-1,3,4-oxadiazol-2-yl]ethyl}chlorobenzenesulfonamide
C17H16ClN3O3S2
Acta Crystallographica Section E (2006) 62, 6 o2449-o2451
a=10.353(3)Å b=7.592(3)Å c=23.655(10)Å
α=90.00° β=100.329(19)° γ=90.00°
4-Methyl-N-[1-(5-thioxo-4,5-dihydro-1,3,4-oxadiazol-2- yl)propyl]benzenesulfonamide
C12H15N3O3S2
Acta Crystallographica Section E (2006) 62, 6 o2481-o2483
a=14.098(5)Å b=16.575(8)Å c=13.695(5)Å
α=90.00° β=114.05(2)° γ=90.00°
Ethyl 2-(benzoyloxy)benzoate
C16H14O4
Acta Crystallographica Section E (2007) 63, 2 o744-o745
a=7.2123(12)Å b=10.4116(17)Å c=18.331(3)Å
α=90.00° β=98.259(4)° γ=90.00°
Ethyl 2-({5-[2-(benzoylamino)phenyl]-1,3,4-oxadiazol-2-yl}sulfanyl)acetate
C19H17N3O4S
Acta Crystallographica Section E (2007) 63, 2 o1021-o1022
a=16.810(3)Å b=5.0834(9)Å c=21.274(4)Å
α=90.00° β=90.00° γ=90.00°
<i>N</i>'-(4-Fluorobenzoyl)-3,4,5-trimethoxybenzohydrazide monohydrate
C17H17FN2O5,H2O
Acta Crystallographica Section E (2007) 63, 6 o3052-o3052
a=8.3845(5)Å b=13.2688(9)Å c=31.833(2)Å
α=90.00° β=94.6150(10)° γ=90.00°
1-[2-(4-Chlorophenyl)acetyl]-4-(2-methoxyphenyl)thiosemicarbazide
C16H16ClN3O2S
Acta Crystallographica Section E (2007) 63, 7 o3299-o3299
a=5.935(5)Å b=16.970(5)Å c=17.038(5)Å
α=90.000° β=98.948(5)° γ=90.000°
3-(4-Fluorobenzyl)-4-(2-methoxyphenyl)-1H-1,2,4-triazole-5(4H)-thione
C16H14FN3OS
Acta Crystallographica Section E (2007) 63, 8 o3501-o3501
a=7.4910(7)Å b=16.1656(15)Å c=12.9147(12)Å
α=90.00° β=91.956(2)° γ=90.00°
Ethyl 2-(5-phenyl-1,3,4-oxadiazol-2-ylsulfanyl)acetate
C12H12N2O3S
Acta Crystallographica Section E (2008) 64, 4 o736
a=8.777(3)Å b=11.008(5)Å c=13.177(6)Å
α=90.00° β=103.59(3)° γ=90.00°
2-[4-Benzyl-5-(2-furyl)-4H-1,2,4-triazol-3-ylsulfanyl]acetamide
C15H14N4O2S
Acta Crystallographica Section E (2008) 64, 7 o1259
a=15.995(9)Å b=7.261(3)Å c=13.598(8)Å
α=90.00° β=105.46(2)° γ=90.00°
4-Ethyl-3-(3-pyridyl)-1<i>H</i>-1,2,4-triazole-5(4H)-thione 0.095-hydrate
C9H10N4S,0.095(H2O)
Acta Crystallographica Section E (2008) 64, 5 o945
a=14.076(5)Å b=8.877(5)Å c=16.216(8)Å
α=90.00° β=93.25(3)° γ=90.00°
4-Benzyl-3-(2-furyl)-1<i>H</i>-1,2,4-triazole-5(4H)-thione hemihydrate
C13H11N3OS,0.5(H2O)
Acta Crystallographica Section E (2008) 64, 6 o952-o953
a=6.082(2)Å b=12.069(4)Å c=17.818(5)Å
α=92.43(2)° β=94.35(2)° γ=103.83(2)°
Trimethoxyhydrazide
C10H14N2O4,0.5H2O
Acta Crystallographica Section E (2006) 62, 8 o3259-o3261
a=33.253(6)Å b=4.8362(8)Å c=14.227(3)Å
α=90.00° β=93.074(16)° γ=90.00°
2-bromobenzoic acid hydrazide
C7H7BrN2O
Zeitschrift für Kristallographie - New Crystal Structures (2006) 221, 3 305-306
a=12.769(3)Å b=12.754(3)Å c=5.0264(11)Å
α=90.00° β=99.874(4)° γ=90.00°